SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-090326
Filing Date
2024-08-05
Accepted
2024-08-05 07:32:25
Documents
1
Period of Report
2024-08-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4405
  Complete submission text file 0000950170-24-090326.txt   5941
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Issuer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TEVA 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Business Address
Jover Placid (Reporting) CIK: 0002026165 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-16174 | Film No.: 241173105